ReviewTherapeutic innovation & regulatory science2022

Changes in Companion Diagnostic Labelling: Implementation of FDA's April 2020 Guidance for Industry for In Vitro CDx Labeling for Specific Oncology Therapeutic Groups.

Lisa Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.